• HOME
  • ABOUT
  • Practice Areas
  • Our Team
  • Accolades
  • Legal Updates
  • Contact
  • עברית

January 28, 2024

ILPTO update: Salt Patents may still be obtained – despite another restrictive ILPTO decision

In a recent decision relating to the tosylate salt of lumateperone, the ILPTO again expressed a highly restrictive view in connection with salt patents. However, salt patents may still be obtained if proper evidence is submitted to establish that the patent is not merely a reflection of routine salt screening. The ILPTO rejected the Patent […]

Latest Posts

  • IL PTE Update: Revocation of Foreign PTE/SPC Can Terminate Israeli PTE Before It Enters into Force01/09/2026
  • ILTMO Update: Professional titles and designations are not registrable as certification marks17/08/2026
  • ILPTO upholds its practice in cases of multiple PTE applications based on the same drug product – a single PTE application must be elected before publication of the notice of intention to grant10/08/2026
  • IL PTE Update: Revocation of a single SPC in the Recognized European Countries invalidates the corresponding IL PTE18/05/2026
  • New ILPTO Commissioner further clarifies the patentability thresholds of polymorphs09/02/2026

Liad Whatstein & Co. © 2026 All Rights Reserved
Credits; Accessibility | נגישות